These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7972625)

  • 21. What's in a drug name?
    Wick JY
    J Am Pharm Assoc (2003); 2004; 44(1):12-4. PubMed ID: 14965147
    [No Abstract]   [Full Text] [Related]  

  • 22. The need for balancing the regulation of pharmaceutical trademarks between the Food and Drug Administration and the Patent and Trademark Office.
    Boring D; Doninger C
    Food Drug Law J; 1997; 52(1):109-16. PubMed ID: 10346714
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary pharmaceuticals manufacturing.
    Burling JN; Shah PV
    Occup Med; 1997; 12(1):29-48. PubMed ID: 9153051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future of the drug label: Perspectives from a multistakeholder dialogue.
    Gispen-de Wied CC; Weemers J; Boon W; Mol PGM; Stolk P
    Br J Clin Pharmacol; 2019 Oct; 85(10):2442-2445. PubMed ID: 31317570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major issues in marketing regulation.
    Pines WL
    Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA mulls over paperless labeling.
    Young D
    Am J Health Syst Pharm; 2007 Jun; 64(11):1120, 1122. PubMed ID: 17519446
    [No Abstract]   [Full Text] [Related]  

  • 29. The dangers of self-dosing.
    Schultz S
    US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369
    [No Abstract]   [Full Text] [Related]  

  • 30. Looking backwards: a possible new path for drug discovery in psychopharmacology.
    Shorter E
    Nat Rev Drug Discov; 2002 Dec; 1(12):1003-6. PubMed ID: 12461521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AHI perspectives: flexible drug labeling and its impact on the drug development process. Practicality of clinical development.
    Copeland DD
    J Am Vet Med Assoc; 1995 Oct; 207(7):895-6; discussion 902-4. PubMed ID: 7559018
    [No Abstract]   [Full Text] [Related]  

  • 33. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 34. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 35. On the accountability problem of the pharmaceutical industry.
    Roberts CD
    Pharmazie; 1973 Jan; 28(1):49-51. PubMed ID: 4714241
    [No Abstract]   [Full Text] [Related]  

  • 36. Premarket notifications of new dietary ingredients--a ten-year review.
    McGuffin M; Young AL
    Food Drug Law J; 2004; 59(2):229-44. PubMed ID: 15318394
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Quantitative formula disclosure.
    Feldman EG
    J Pharm Sci; 1974 Dec; 63(12):1. PubMed ID: 4449011
    [No Abstract]   [Full Text] [Related]  

  • 39. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 40. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.